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Acetaldehyde (ACD) is the first metabolite of ethanol. Although, the role of ACD in ethanol 
addiction has been controversial, there are data showing a relationship. The objective of the 
current study was to further test the hypothesis that ACD itself is reinforcing. For this reason, 
we carried out a study on operant oral ACD self-administration. Wistar rats were trained to 
self-administer tap water or ACD by nose-poking in daily 30 min sessions for 15 consecutive 
days. Response on active nose-poke caused delivery of ACD solution or tap water, whereas 
responses on inactive nose-poke had no consequences. The results show that ACD maintains 
oral self-administration behavior and rates of active nose-pokes significantly higher than tap water. 
The dose–response plot for oral ACD self-administration is a “bell-shaped” curve suggesting 
reinforcing properties only in a limited range of doses. Furthermore, rats self-administering ACD 
show a deprivation effect upon ACD removal and gradually reinstated active nose-poke response 
when ACD was reintroduced. Overall, this study shows that ACD is orally self-administered and 
further supports the hypothesis that ACD possesses reinforcing properties, which suggests that 
some of the pharmacological effects attributed to ethanol may result from its biotransformation 
into ACD, thereby supporting an active involvement of ACD in ethanol addiction.
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transmission in the nucleus accumbens (Melis et al., 2007; Enrico 
et al., 2009). Further, Vinci et al. (2010) reported that ACD elicits 
extracellular signal-regulated kinase (ERK) phosphorylation in the 
rat Nacc and extended amygdala (Vinci et al., 2010). Overall, these 
evidences contribute to the suggestion that ACD is a compound 
with intrinsic motivational and rewarding effects.
The objective here is to further test the hypothesis that ACD 
itself could be reinforcing. For this reason, we carried out a study on 
acquisition, maintenance (stable baseline), and deprivation effect 
in ACD-drinking behavior.
Materials and Methods
The study was carried out in accordance with current Italian legisla-
tion [D.L. 116, 1992] which allows experimentation on laboratory 
animals only after submission and approval of a research project to 
the Ministry of Health (Rome-Italy), and in strict accordance with 
European Council directives on the matter [n. 2007/526/CE]. All 
possible efforts were made to minimize animal pain and discomfort 
and to reduce the number of experimental subjects.
aniMals
Male Wistar rats (Harlan, Udine, Italy), weighing 175–225 g, were 
housed in groups of two and maintained under controlled envi-
ronmental conditions (temperature 22 ± 2°C; humidity 60–65%) 
on a reverse 12-h light/dark cycle (light on at 18:00 hours; off at 
06:00 hours). In order to limit animal stress, the rats were housed in 
the same room where the operant chambers were located. Standard 
laboratory rat chow and tap water (two bottles) were available ad 
libitum in the home cage, with the exceptions noted below. All 
training and experimental sessions were conducted during the 
introduction
Although  well  known  for  its  toxicity  (Novartis  Foundation, 
2007), acetaldehyde (ACD) is recognized by the Food and Drug 
Administration as a safe compound (FDA, 2008). ACD is the first 
metabolite of ethanol and is also a major component of tobacco 
smoke (Talhout et al., 2007). In addition, ACD is also present in 
alcoholic drinks such as beer, wine, sake, and whiskey and in very 
small amounts in some fermented foods (Liu and Pilone, 2000; 
Novartis Foundation, 2007; Talhout et al., 2007). ACD, however, 
first evokes to pharmacologists and physicians its indirect use as 
deterrent to discourage drinking in alcoholic patients. In fact, 
disulfiram and other aldehyde dehydrogenases inhibitors induce 
elevated blood ACD concentrations and elicit the strong aversive 
syndrome, known as flushing reaction (Quertemont et al., 2005; 
Suh et al., 2006). On the other hand, some authors reported that 
patients benefited by taking low doses of ethanol when under 
disulfiram treatment (Chevens, 1953; Brown et al., 1983). However, 
the interest in ACD as a compound with potential addictive effects 
has been revitalized in the last decade by a number of studies, sug-
gesting the possibility that ethanol effects could be mediated by 
its first metabolite, ACD (Quertemont et al., 2005). Experimental 
evidence supports the notion that motivational properties of etha-
nol are mediated by ACD (McBride et al., 2002; Font et al., 2006; 
Peana et al., 2008a, 2009). Moreover, a wealth of studies suggest 
that ACD itself could produce positive reinforcing effects (Brown 
et al., 1979; Myers et al., 1984; Smith et al., 1984; Takayama and 
Uyeno, 1985; Quertemont and De Witte, 2001; Rodd-Henricks 
et al., 2002). Interestingly, ACD itself and as a consequence of the 
metabolism of ethanol, activates neuronal firing of dopaminergic 
neurons in the VTA (Foddai et al., 2004) and stimulates dopamine Frontiers in Psychiatry  |  Addictive Disorders    September 2010  | Volume 1  | Article 23  |  2
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For the study of ACD dose–response another group of rats 
(n = 5) was trained in a daily 30 min session to ACD self-admin-
ister at concentrations starting from day 7 until 11 at 0.1% and 
then gradually increased through 0.2–3.2%, every 5 days for each 
concentration session.
In the extinction paradigm, subjects (n = 5) are trained to 
orally self-administer ACD until stable self-administration pat-
terns are achieved, at which point ACD is removed. Extinction 
testing sessions are identical to training sessions except that there 
is no ACD (0.2%). Our extinction period lasted five consecutive 
days and during this time, responses at the active nose-poke set 
off the delivery mechanism. Following the last extinction session, 
began the deprivation-effect sessions. These sessions lasted 30 min 
under conditions identical to those during the self-administration 
session with availability of ACD solution at 0.2% and proceeded for 
a further 5 days. Response at the inactive nose-poke was constantly 
recorded to monitor possible non-specific behavioral effects.
MeasureMents of blood and brain acetaldehyde levels
Immediately after the final session of self-administration, animals 
were anesthetized with ketamine and medetomidine (75 + 0.5 mg/
kg/ml, i.p.) and about 10 min afterward blood samples and brain 
were taken. For analysis, a 1-ml aliquot of rat blood was diluted 
with 1 ml of cold milliQ water in 10 ml HS-vials (Hewlett-Packard). 
The brains, on the other hand, were homogenized with 1 ml of cold 
milliQ water in 10 ml HS-vials (Hewlett-Packard) for analysis. The 
vials were placed in a heating block at 45°C for 10 min. The sam-
ples were analyzed on HS-GC-FID system with a Dani 86.50 HSS-
autosampler, and a Hewlett-Packard gas chromatography HP 6890 
Plus. An Econo CAP EC-5 (Alltech, Italy) capillary column used was 
(30 m, 0.53 mm i.d., 1.2 μm d.f.). The injection port temperature 
was maintained at 250°C. GC oven temperature was maintained at 
45°C in isothermal conditions for 8 min. The flow rate of helium 
carrier gas was 6.1 ml/min and the FID temperature was maintained 
at 250°C. HS parameters were: 75°C manifold temperature, 150°C 
transferline temperature, 1.57 PSI carrier gas pressure, 1 min vial 
pressurization time, and 1 ml injection volume of headspace gas.
statistical analysis
Data were analyzed by one-way analysis of variance (ANOVA) 
or  two-way ANOVA  for  repeated  measures  and  are  expressed 
as mean ± S.E.M. Post hoc comparisons, using Tukey’s Honestly 
Significant Difference (HSD) test, were undertaken if a significant 
effect was found (p < 0.05). In addition, for each individual group-
ing, nose-poke discrimination was determined by type (active or 
inactive) × session multivariate ANOVA (MANOVA) with F-values 
derived from Wilk’s Lambda.
results
Figure 1, illustrates that rats (n = 11) showed a higher number of 
responses for ACD solution versus tap water (n = 5) during the 
acquisition session [active nose-poke: F(1.14) = 4.69, p = 0.048]; 
session: F(14.196) = 8.92, p < 0.00001 but not an active nose-
poke × session interaction effect]. In addition, nose-poke dis-
crimination (active against inactive nose-pokes) was present for 
the major part of acquisition sessions [Wilks’ Lambda: 0.000793; 
Rao’s R: 420.1407; p < 0.0001; one-way MANOVA analysis].
dark phase of the cycle (Testa and Badiani, 2008). We performed 
the experiment during the dark phase, when is more evident the 
drinking behavior (Kamdar et al., 2007).
drugs
Acetaldehyde  (Sigma-Aldrich,  Milano,  Italy)  was  dissolved  in 
tap water as w/v. All dilutions were freshly prepared before every 
experimental session. So as to avoid ACD evaporation, we prepared 
the solutions keeping the preparation beaker under ice. In addi-
tion, ACD was always used in this diluted form which reduced 
surface tension.
apparatus
Training and testing were conducted in modular operant chambers 
located in ventilated sound-attenuating environmental cubicles 
(Med Associates Inc, USA). Each chamber was equipped with a 
non-retractable drinking reservoir (capacity 0.50 ml) and two nose-
poke holes, located at 3 cm to the left and right of the reservoir. As 
discriminative stimuli, a white light was placed over the active hole 
and a red light over the inactive one. Only the active nose-poke set 
off the dipper delivering the solution (0.1 ml) and was recorded. 
Explorations on the other inactive nose-poke were also recorded. 
This served to control for specificity of response in the operant 
chamber. The availability of liquid was signaled by a white house 
light placed on the wall in front of the liquid delivery system and 
would light up for the duration of liquid delivery. Following each 
delivery, there was a 2-s time-out period during which response 
had no consequences and the white light placed over the active hole 
would go off. An infrared head detector was located in the reservoir 
and recorded all signals during the whole session lasting 30 min. 
Chambers were interfaced to a computer equipped with software 
that programmed sessions as well as data recording.
operant procedures
Rats (n = 11) learned how to obtain ACD solution by nose-poke. 
During the self-administration period, we repeatedly evaluated 
active and inactive nose-pokes as well as ACD intake in relation to 
each rat’s weight (g/kg) for each daily 30-min session. For operant 
ACD self-administration (full range 0.1–0.2%), rats were trained 
to nose-poke on a fixed-ratio 1 schedule of reinforcement, where 
each response resulted in 0.1 ml solution delivery. One day before 
(pre-training) and for the first 2 days of training, tap water avail-
ability in the home cage was restricted to 5 min/day in order to 
facilitate acquisition of operant response. From this point onwards, 
tap water was continuously available in the home cage. During this 
time (3 days, deprived + 3 days, not deprived), rats were permitted 
to nose-poke explore for 0.1% ACD solution Starting on day 7, ACD 
solution concentration was gradually increased in stages from 0.12 
to 0.14, 0.16, and 0.18 ending up at the final concentration of 0.2%. 
Following completion (11 days) of the ACD training the rats were 
trained to nose-poke explore for another 4 days: this served to reach 
a stable responding baseline (maintenance). Inactive nose-poke 
responses were recorded during all testing phases as a measure 
of non-specific behavioral response. An additional group of five 
rats was included and these were given the opportunity to orally 
self-administer tap water and trained under the same experimental 
conditions as the ACD group.www.frontiersin.org  September 2010  | Volume 1  | Article 23  |  3
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to tap water (n = 5). Moreover, responses on the active nose-poke 
showed no variation between ACD solution at 0.1 and 3.2%, and 
tap water (Figure 3).
Following completion of ACD training (maintenance or stable 
baseline of drinking), the rats (n = 5) were subjected to a period of 
ACD extinction for 5 days and afterward resumed ACD self-admin-
istration for 5 days. The amount of response on the now reactivated 
nose-poke was used to reflect the motivation for ACD-drinking 
behavior. During these sessions the rats responded significantly 
more on the active than the inactive nose-poke. Our MANOVA 
data show that the subjects discriminated between active and inac-
tive nose-pokes before, [Wilks’ Lambda: 0.031; Rao’s R: 25.0065; 
p = 0.004], and after extinction session [Wilks’ Lambda: 0.023; 
Rao’s R: 33.732; p = 0.002], but not during the 5-day extinction 
session (Figure 4).
As can be seen in Table 1, following the final session of oral 
ACD self-administration, ACD levels in blood were increased up to 
62% (n = 8) with respect to the tap water group (n = 4). One way 
ANOVA showed a significant effect of treatment [F(1.20) = 2.30, 
p < 0.05]. In contrast, brain ACD levels were identical in the two 
grouping (data not shown).
Further, Figure 2, shows the corresponding ACD intake (mg/
kg) as a function of active nose-poke in the ACD same grouping. 
One-way ANOVA on the average intake during the 15 sessions 
revealed a significant intake effect [F(14.150) = 9.01, p < 0.00001]. 
In general, the animals consumed more ACD with respect to the 
first (tap water deprived) and fourth (not deprived) sessions of 
self-administration. Consumatory responses, was measured, also 
by head entries throughout the session period (about 170% with 
respect to total infusions).
For the analysis of ACD dose–response (n = 5), the number 
of active nose-pokes during the final 3 ACD self-administration 
sessions was averaged to obtain a mean value for ACD self-admin-
istration (Figure 3). One-way ANOVA on the average number of 
active nose-pokes explorations revealed a significant effect of con-
centration [F(6.14) = 6.54, p = 0.0018]. Post hoc comparisons indi-
cated that the 0.2, 0.4, 0.8, and 1.6% ACD concentrations induced 
significantly more exploration of active nose-pokes (p < 0.05) with 
respect to the 0.1 and 3.2% concentrations, as well as with respect 
Figure 1 | Oral ACD self-administration behavior. Responses per session 
(30 min) on the active and inactive nose-pokes by rats trained for acquisition of 
oral tap water or ACD self-administration. ∆p < 0.05 between tap water and 
ACD, active nose-pokes (two-way ANOVA for repeated measures and Tukey’s 
post hoc test). Data are mean ± SEM.
Figure 2 | Acetaldehyde intake expressed in mg/kg during the above 
(Figure 1) operant session (30 min) as function of active nose-poke in the 
same ACD group. *p < 0.05 with respect to the 1° and 4°day of ACD session 
(one-way ANOVA and Tukey’s post hoc test). Data are mean ± SEM.
Figure 3 | Average number of active nose-pokes during the last three 
sessions of oral self-administration as a function of ACD concentration 
(each ACD concentration was tested for 5 days) in Wistar rats. Asterisk 
indicate significant difference (p < 0.05) with Tukey’s test. Data are 
mean ± SEM.
Figure 4 | Deprivation effect after ACD extinction. Average number 
(mean ± SEM) of active and inactive nose-pokes during five sessions of oral 
self-administration. Asterisk indicate significant difference (p < 0.05).Frontiers in Psychiatry  |  Addictive Disorders    September 2010  | Volume 1  | Article 23  |  4
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On the other hand, we found no differences in ACD levels in 
the brain between the two grouping, probable due to low brain 
ACD penetration. In this context, ACD was actually consumed 
at  very  low  doses  considering  that  the  amount  in  mg/kg  was 
ingested over a 30-min session and not in a single bolus. We can-
not exclude that other experimental protocols might give different 
results; indeed, several reports have pointed out the difficulties 
affecting ACD measurement in the brain, particularly due to the 
low levels usually encountered and very few studies have reported 
detectable brain ACD levels after peripheral ACD administration. 
Overall, ACD determination is difficult and compromised by its 
rapid conversion to acetate, via aldehyde dehydrogenase (Deng and 
Deitrich, 2008). In fact, rapid ACD oxidation, may markedly affect 
the recovery of low ACD levels. Moreover, ACD, like other volatiles, 
is eliminated by breath crossing the alveolar-capillary membrane 
of the lungs (Novartis Foundation, 2007). Nevertheless, ACD easily 
reacts with many other molecules by adduction, condensation and 
polymerization, which are important in the brain, and these could 
be plausible explanations for why we did not detect ACD in the 
brain. Some authors reported that cerebral venous blood ACD (not 
brain) levels were detected after a high ACD dose (Quintanilla and 
Tampier, 2003). Moreover, studies, which have utilized high doses 
of ACD, demonstrated that ACD, analyzed by HPLC, was present 
in rat brain after a single intraperitoneal injection of ACD (Heap 
et al., 1995). It is important to note that we analyzed brain samples 
by gas chromatography with the headspace.
The  exact  mechanism  underlying  ACD  behavioral  effects 
remains  largely  unknown.  ACD  could  play  a  mediatory  role 
on  the  neurobehavioral  consequences  observed  after  ethanol 
administration. Even the mechanism of ethanol actions is still 
debated although multiple molecular targets have been identi-
fied. Nevertheless, there have been significant advancements in 
understanding of ACD central effects in recent years. Previous 
findings of our research group showed that the peripheral com-
petitive inhibitor of alcohol dehydrogenase, 4-methylpyrazole, 
decreased ethanol-induced conditioned place preference and oral 
ethanol self-administration in Wistar rats (Peana et al., 2008a,b). 
These findings were supported by the efficacy of selective ACD 
sequestrating agents, d-penicilamine and l-cysteine, to prevent 
ethanol- and ACD-induced conditioned place preference in Wistar 
rats (Peana et al., 2008a, 2009). In agreement, l-cysteine inhibited 
oral ethanol self-administration in Wistar rats (Peana et al., 2010) 
and d-penicilamine reduced voluntary ethanol consumption (Font 
et al., 2006). The present observations that ethanol-derived ACD 
and ACD elicits positive motivational properties are in agreement 
with recent studies reporting that intragastric ACD and ethanol-
derived ACD could share with addictive drugs the property to 
induce ERK phosphorylation in the Sprague-Dawley’s rat Nacc 
and extended amygdala (Vinci et al., 2010). Moreover, another 
study demonstrates that blockade of MEKs prevents ACD elic-
ited conditioned place preference in Sprague-Dawley rats (Spina 
et al., 2010). Furthermore, previous work reported that ACD and 
ethanol-derived ACD increased the firing rate of dopaminergic 
neurons in VTA in Wistar rats (Foddai et al., 2004; Enrico et al., 
2009). In patch-clamp studies, Melis et al. (2007) showed that ACD 
increased the inward current in DA neurons, suggesting a direct 
effect for ACD on dopaminergic neural membranes.
discussion
Acetaldehyde addicting effects are still under debate. Therefore, 
the aim of the current study was to further test the hypothesis that 
ACD itself is reinforcing. The results of these experiments show (1) 
that ACD elicits a greater number of active nose-pokes for ACD 
versus tap water during the acquisition of oral self-administration 
behavior and (2) discriminatory behavior between active and inac-
tive nose-pokes. However, oral ACD self-administration did not 
modify the number of the inactive nose-pokes with respect to the 
tap water grouping; indicating an absence of non-specific behav-
ioral effects as well as an absence of motor properties. Without any 
prior operant experience, the rats learned to discriminate the active 
from the inactive nose-poke by day 5 of the initial ACD acquisition 
period. As well, from day 9 of acquisition, the active nose-pokes for 
oral ACD self-administration were significantly higher than for tap 
water. Oral ACD self-administration (0.2%) induced an average 
intake of about 20 mg/kg/session similar to the intragastric dose 
of ACD (20 mg/kg) previously found to induce conditioned place-
preference in Wistar rats (Peana et al., 2008a, 2009).
In addition, ACD self-administration shows a “bell-shaped” 
curve, suggesting the presence of reinforcing properties within a 
limited dosage range. Rats orally self-administered ACD at con-
centrations as low as 0.2 up to 1.6% with the lowest (0.1%) and 
highest concentrations (3.2%) not self-administered. The decrease 
in oral self-administrations as the concentrations increased to over 
0.8% might be due to the higher doses producing a greater effect 
per delivery so that fewer nose-pokes were needed to give the same 
effect. In addition, the lack of oral ACD self-administration at the 
higher concentrations could be due to development of acute toler-
ance to ACD or a result of the toxic/aversive effects of the substance 
(Quertemont and De Witte, 2001). The “bell-shaped” plot for ACD 
was somewhat similar to the dose–response plot seen for ACD 
and ethanol in VTA self-administration studies (Rodd-Henricks 
et al., 2000, 2002). The dose–response data indicates that the low-
est limit for producing a reinforcing effect in ACD is around 0.2%. 
Furthermore, rats that self-administered 0.2% of ACD, showed 
extinction behavior with a loss of nose-poke discrimination and 
subsequently, after ACD restoration, a gradual reinstatement of 
active nose-poke response.
The innovation of the present report is that ACD was orally 
self-administered. In particular, during the final session of ACD 
self-administration, consumatory responses were confirmed by a 
relevant increase (62%) in ACD blood levels with respect to the 
tap water animal grouping. Our findings on blood ACD levels are 
of importance because the physiochemical properties of ACD have 
been the focus of continuing interest and controversy regarding the 
its neurobehavioral actions.
Table 1 | Acetaldehyde blood levels.
Treatment  ACD intake  ACD level  % increase 
  (mg/kg)  (mg/ml)
Saline/ACD  20.00 ± 2.11  0.0073 ± 0.0010  62
Saline/tap water    0.0045 ± 0.0016   
Results are presented as the mean ± SEM.www.frontiersin.org  September 2010  | Volume 1  | Article 23  |  5
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